ADAG is a startup based in the United States, most recent round Pre-ipo.
Based in the United States, ADAG is a startup. Its most recent tracked round is Pre-ipo.
ADAG is a clinical-stage immunotherapy and biopharmaceutical company developing targeted therapies, including antibody-drug conjugates, for cancer treatment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.